Total Payments
$9,630
2024 Payments
$2,431
Companies
35
Transactions
594
Medicare Patients
2,673
Medicare Billing
$283,654
Payment Breakdown by Category
Food & Beverage$9,615 (99.8%)
Education$14.48 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,615 | 589 | 99.8% |
| Education | $14.48 | 1 | 0.2% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$9,630
590 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,446 | 202 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,088 | 95 | $0 (2024) |
| Celgene Corporation | $860.85 | 56 | $0 (2024) |
| Gilead Sciences, Inc. | $607.50 | 39 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $348.17 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $323.66 | 16 | $0 (2024) |
| Romark Laboratories, LC | $277.92 | 30 | $0 (2020) |
| Lilly USA, LLC | $244.65 | 11 | $0 (2024) |
| PFIZER INC. | $240.74 | 15 | $0 (2024) |
| GENZYME CORPORATION | $230.46 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,431 | 106 | ABBVIE INC. ($941.01) |
| 2023 | $1,291 | 83 | Celgene Corporation ($386.51) |
| 2022 | $1,335 | 90 | ABBVIE INC. ($407.61) |
| 2021 | $1,134 | 80 | AbbVie Inc. ($456.72) |
| 2020 | $652.72 | 41 | AbbVie Inc. ($197.12) |
| 2019 | $1,062 | 68 | AbbVie, Inc. ($338.86) |
| 2018 | $919.89 | 72 | AbbVie, Inc. ($237.58) |
| 2017 | $804.78 | 54 | AbbVie, Inc. ($481.59) |
All Payment Transactions
594 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: VIROLOGY | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $112.62 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: LIVER DISEASE | ||||||
| 10/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Gastroenterology | ||||||
| 10/11/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: LIVER DISEASE | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $110.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: VIROLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 583 | 608 | $331,811 | $65,435 |
| 2022 | 11 | 752 | 771 | $418,037 | $81,682 |
| 2021 | 13 | 728 | 766 | $372,124 | $78,742 |
| 2020 | 13 | 610 | 675 | $274,543 | $57,795 |
Total Patients
2,673
Total Services
2,820
Medicare Billing
$283,654
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 89 | 91 | $106,561 | $17,310 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 92 | $21,620 | $8,019 | 37.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 40 | 40 | $32,120 | $7,164 | 22.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 64 | 65 | $57,395 | $6,683 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 105 | $16,800 | $6,501 | 38.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 79 | 79 | $46,768 | $5,770 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $13,505 | $4,336 | 32.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 24 | 24 | $19,632 | $4,297 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $10,575 | $2,978 | 28.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,030 | $1,320 | 32.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 17 | $2,805 | $1,056 | 37.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 106 | 107 | $125,297 | $20,709 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 109 | $25,615 | $9,952 | 38.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 120 | 121 | $71,632 | $8,303 | 11.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 45 | 45 | $36,135 | $8,110 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $24,455 | $8,039 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 117 | $18,720 | $7,643 | 40.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $60,927 | $6,703 | 11.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 77 | 77 | $18,095 | $5,337 | 29.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 19 | 19 | $15,542 | $3,182 | 20.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $18,814 | $2,749 | 14.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 17 | $2,805 | $954.80 | 34.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 72 | 73 | $85,483 | $14,107 | 16.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 142 | 160 | $25,600 | $10,888 | 42.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 105 | $24,675 | $10,435 | 42.3% |
About Dr. Sheila Reddy, M.D
Dr. Sheila Reddy, M.D is a Gastroenterology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1144579699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheila Reddy, M.D has received a total of $9,630 in payments from pharmaceutical and medical device companies, with $2,431 received in 2024. These payments were reported across 594 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,615).
As a Medicare-enrolled provider, Reddy has provided services to 2,673 Medicare beneficiaries, totaling 2,820 services with total Medicare billing of $283,654. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Austin, TX
- Active Since 08/30/2012
- Last Updated 08/20/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1144579699
Products in Payments
- ZEPOSIA (Drug) $860.85
- RINVOQ (Biological) $858.31
- XIFAXAN (Drug) $854.11
- Humira (Biological) $645.69
- HUMIRA (Biological) $394.06
- SKYRIZI (Biological) $387.55
- DUPIXENT (Biological) $379.19
- STELARA (Biological) $287.90
- TREMFYA (Drug) $263.81
- MAVYRET (Drug) $245.15
- OMVOH (Drug) $244.65
- Mavyret (Drug) $228.76
- LINZESS (Drug) $215.15
- DIFICID (Drug) $212.31
- Cimzia (Drug) $211.93
- TRULANCE (Drug) $202.71
- XELJANZ (Drug) $199.03
- VIBERZI (Drug) $182.71
- Entyvio (Biological) $154.55
- IBSRELA (Drug) $151.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Austin
Dr. Harish Gagneja, Md, MD
Gastroenterology — Payments: $760,415
Gastroenterology $760,415
Harry Thomas, Md, MD
Gastroenterology — Payments: $360,300
Gastroenterology $360,300
Dr. Pradeep Kumar, M.d, M.D
Gastroenterology — Payments: $94,961
Gastroenterology $94,961
Dr. Jianhua Tau, M.d, M.D
Gastroenterology — Payments: $90,140
Gastroenterology $90,140
Dr. Scott Becker, M.d, M.D
Gastroenterology — Payments: $46,704
Gastroenterology $46,704
Binh Pham, M.d, M.D
Gastroenterology — Payments: $37,217
Gastroenterology $37,217